Bank of America’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23
| Closed | -$26 | – | 8307 |
|
|
2023
Q4 | $26 | Sell |
23
-18
| -44% | -$26 | ﹤0.01% | 7611 |
|
|
2023
Q3 | $76 | Buy |
+41
| New | +$217 | ﹤0.01% | 7482 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7672 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7691 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$144 | – | 8085 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | +$400 | ﹤0.01% | 8308 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | -$549 | – | 8531 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 8156 |
|
|
2021
Q4 | $1K | Buy |
+1
| New | +$1.26K | ﹤0.01% | 8108 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8481 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8182 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7439 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7253 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7195 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7345 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7471 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7479 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7451 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7521 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7384 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 7399 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6943 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6960 |
|
|
2017
Q2 | – | Hold |
0
| – | -$5K | – | 7230 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6681 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6756 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6509 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6828 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6655 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7117 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6982 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6828 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6515 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | -$31.3K | – | 7181 |
|
|
2014
Q3 | $28K | Sell |
1
-8
| -89% | -$226K | ﹤0.01% | 6867 |
|
|
2014
Q2 | $249K | Buy |
+9
| New | +$230K | ﹤0.01% | 5351 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7081 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | -$23.7K | – | 7098 |
|
|
2013
Q3 | $16K | Sell |
1
-3
| -75% | -$96.6K | ﹤0.01% | 6989 |
|
|
2013
Q2 | $196K | Buy |
+4
| New | +$224K | ﹤0.01% | 5637 |
|
Other funds holding BIOL
VF
HF
XT
KWA
Bank of America's BIOL Position: Q1 2024 in Review
Bank of America sold out of Biolase, Inc. (BIOL) in Q1 2024, closing a stake of 23 shares — an estimated $26 sold.
Bank of America first reported a position in BIOL in Q2 2013 and held it in 9 quarters. The position peaked at $249K in Q2 2014. 18 funds tracked by Wall St. Rank hold BIOL as of Q1 2024.
- Bank of America reported no remaining Biolase, Inc. position as of Q1 2024 after selling out during the quarter.
- Bank of America sold 23 Biolase, Inc. shares in Q1 2024, an estimated $26.
- Bank of America first reported a position in Biolase, Inc. in Q2 2013 and held it in 9 quarters.
- Bank of America's Biolase, Inc. position peaked at $249K in Q2 2014.
- 18 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2024.
Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.